Seoul, South Korea

Jonathan Cechetto

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Institut Pasteur Korea, National Institute of Health and Medical Research. Active years: 2014.

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Jonathan Cechetto

Introduction

Jonathan Cechetto is an accomplished inventor based in Seoul, South Korea. He has made significant strides in the field of medical innovation, particularly focusing on combating bacterial infections.

Latest Patents

Jonathan holds a patent for anti-infective compounds that relate to small molecule compounds used in the treatment of bacterial infections, especially Tuberculosis. This invention showcases his dedication to improving healthcare solutions and addressing critical health issues faced worldwide.

Career Highlights

Throughout his career, Jonathan has contributed his expertise to reputable organizations, including Institut Pasteur Korea and the Institut National De La Santé Et De La Recherche Médicale. His work in these institutions has solidified his reputation as a valuable innovator in the field of medical research.

Collaborations

Jonathan has worked alongside talented colleagues such as Zaesung No and Jaeseung Kim. These collaborations have fostered an environment of innovation and advancement in research, contributing to the effective development of new treatments and solutions in healthcare.

Conclusion

Jonathan Cechetto's contributions to the field of medical innovation demonstrate the impact that dedicated inventors can have on society. His work in developing anti-infective compounds positions him as a key player in the fight against bacterial infections, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…